576MO Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Fizazi, K., Herrmann, K., Krause, B.J., Rahbar, K., Chi, K.N., Morris, M.J., Sartor, O., Tagawa, S.T., Kendi, A.T., Vogelzang, N.J., Calais, J., Nagarajah, J., Wei, X.X., Koshkin, V.S., Beauregard, J-M., Chang, B., DeSilvio, M., Messmann, R.A., de Bono, J.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Sartor, Oliver, de Bono, Johann, Chi, Kim N., Fizazi, Karim, Herrmann, Ken, Rahbar, Kambiz, Tagawa, Scott T., Nordquist, Luke T., Vaishampayan, Nitin, El-Haddad, Ghassan, Park, Chandler H., Beer, Tomasz M., Armour, Alison, Pérez-Contreras, Wendy J., DeSilvio, Michelle, Kpamegan, Euloge, Gericke, Germo, Messmann, Richard A., Morris, Michael J., Krause, Bernd J.
Published in The New England journal of medicine (16.09.2021)
Published in The New England journal of medicine (16.09.2021)
Get full text
Journal Article
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan
MATTESON, E. L, LOWE, V. J, PRENDERGAST, F. G, CROWSON, C. S, MODER, K. G, MORGENSTERN, D. E, MESSMANN, R. A, LOW, P. S
Published in Clinical and experimental rheumatology (01.03.2009)
Get full text
Published in Clinical and experimental rheumatology (01.03.2009)
Journal Article
Résultats de qualité de vie liée à la santé, douleur et tolérance de l’étude de phase 3 VISION du 177Lu-PSMA-617 chez des patients atteints d’un CPRCm
Fizazi, K., Flippot, R., Hermann, K., Krause, B.J., Rahbar, K., Chi, K.N., Morris, M.J., Sartor, O., Tagawa, S.T., Kendi, A.T., Vogelzang, N., Calais, J., Nagarajah, J., Wei, X.X., Koshkin, V.S., Beauregard, J.M., Chang, B., DeSilvio, M., Messmann, R.A., de Bono, J.
Published in Médecine nucléaire : imagerie fonctionelle et métabolique (01.03.2022)
Published in Médecine nucléaire : imagerie fonctionelle et métabolique (01.03.2022)
Get full text
Journal Article
Étude de phase 3 du 177Lu-PSMA-617 dans le traitement des patients atteints d’un cancer de la prostate métastatique résistant à la castration (CPRCm) (VISION)
Fizazi, K., Flippot, R., Morris, M.J., De Bono, J., Chi, K.N., Herrmann, K., Rahbar, K., Tagawa, S.T., Nordquist, L.T., Vaishampayan, N., El-Haddad, G., Park, C.H., Beer, T.M., Pérez-Contreras, W.J., DeSilvio, M., Kpamegan, E., Gericke, G., Messmann, R.A., Krause, B.J., Sartor, O.
Published in Médecine nucléaire : imagerie fonctionelle et métabolique (01.03.2022)
Published in Médecine nucléaire : imagerie fonctionelle et métabolique (01.03.2022)
Get full text
Journal Article